(University of Texas M. D. Anderson Cancer Center) Participating in twice-weekly practice of Tibetan yoga may reduce sleep disturbances and improve sleep quality in breast cancer patients receiving chemotherapy, according to a study from researchers at The University of Texas MD Anderson Cancer Center.
Devils announced Tuesday that veteran center Brian Boyle has been diagnosed with chronic myeloid leukemia, a bone marrow cancer.
(University of Texas M. D. Anderson Cancer Center) Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a new challenge for oncologists, one addressed by a...Show More Summary
(University of Iowa Health Care) University of Iowa Holden Comprehensive Cancer Center and Mayo Clinic have received a five-year, $12.4 million grant renewal from the National Cancer Institute to continue the Specialized Program of Research Excellence for lymphoma research. Show More Summary
Roswell Park Cancer has joined the Oncology Research Information Exchange Network, a unique research partnership among North America's top cancer centers. Members of ORIEN contribute to a shared databank and collaborate on clinical research in order to develop new and better treatment options for cancer patients.
(Duke University Medical Center) Researchers at Duke Cancer Institute have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.
The University of California's five academic cancer centers, home to some of the world's leading scientists and physicians, have formed a consortium to better address California's most pressing cancer-related problems and opportunities, UC President Janet Napolitano and Dr. John Stobo, executive vice president of UC Health, announced today.
The University of Texas MD Anderson Cancer Center and Daiichi Sankyo Company, Limited today announced a multi-year collaboration focused on accelerating the development of novel therapies for acute myeloid leukemia (AML).
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and Daiichi Sankyo Company, Limited today announced a multi-year collaboration focused on accelerating the development of novel therapies for acute myeloid leukemia (AML).
(University of Chicago Medical Center) Lymphatic vessels, often blamed for enabling cancer cells to spread from a primary location to many other sites, have a flip side. A team of researchers found that in patients being treated with...Show More Summary
Ben Z. Stanger, MD, PhD, an associate professor of Gastroenterology, has been appointed director of the Penn Pancreatic Cancer Research Center, which includes a multidisciplinary team of pancreatic cancer experts who care for patients and conduct research on the causes and possible prevention and cure of the disease.
William Atkinson is the 2017 recipient of the Julie and Ben Rogers Award for Excellence in Administration at The University of Texas MD Anderson Cancer Center. The annual award recognizes employees who consistently demonstrate excellence in their work and dedication to MD Anderson's mission to end cancer. Show More Summary
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) New immune therapies are considered a promising lead for treating recurring acute myeloid leukemia (AML). Antibodies are able to eliminate even those cancer cells that cannot be removed via regular therapies. Show More Summary
(Louisiana State University Health Sciences Center) Genetic research conducted at LSU Health New Orleans School of Medicine and Stanley S. Scott Cancer Center demonstrated for the first time that a novel protein can cause normal cells in the lining of the colon to become malignant, grow and spread, as well as take on the characteristics of stem cells.
(University of California - Los Angeles Health Sciences) Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have initiated a phase 1 clinical trial to test a novel cancer treatment for certain kinds of cancers that have a specific tumor marker called NY-ESO-1.
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) Liver cancer occurs predominantly in patients whose liver has been damaged as a result of chronic disease. Scientists from the German Cancer Research Center and the University of Zurich has now shown that chronic cell death promotes the development of cancer. Show More Summary
The Gene Editing Institute of Christiana Care's Helen F. Graham Cancer Center & Research Institute signs agreement with ABS to modify cell lines to accelerate cancer therapies
(Helmholtz Zentrum München - German Research Center for Environmental Health) Taxanes inhibit cell division and make cancer cells sensitive to radiation therapy. A current study has investigated the underlying mechanisms of this action - and which biomarkers may be useful for predicting the success of therapy. Show More Summary
Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have initiated a phase 1 clinical trial to test a novel cancer treatment for certain kinds of cancers that have a specific tumor marker called NY-ESO-1.
(UNC Lineberger Comprehensive Cancer Center) The cost savings for the generic versions of an orally administered cancer treatment were less than expected in an analysis led by researchers from the UNC Lineberger Comprehensive Cancer Center. Their findings call into question the impact generic drugs can have on controlling health care costs.